title: Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
authors.affiliation: UCB Pharma, 208 Bath Rd., Slough, Berkshire SL1 3WE, UK; UCB Pharma, Brussels, Belgium; Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA. Electronic address: Simon.Borghs@ucb.com.
authors.forename: Simon
authors.initials: S
authors.lastname: Borghs
authors.affiliation: UCB Pharma, 208 Bath Rd., Slough, Berkshire SL1 3WE, UK; UCB Pharma, Brussels, Belgium; Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.
authors.forename: Mata
authors.initials: M
authors.lastname: Charokopou
authors.affiliation: UCB Pharma, 208 Bath Rd., Slough, Berkshire SL1 3WE, UK; UCB Pharma, Brussels, Belgium; Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.
authors.forename: Christian
authors.initials: C
authors.lastname: Brandt
authors.affiliation: UCB Pharma, 208 Bath Rd., Slough, Berkshire SL1 3WE, UK; UCB Pharma, Brussels, Belgium; Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.
authors.forename: Pavel
authors.initials: P
authors.lastname: Klein
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006801:Humans; D000077287:Levetiracetam; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D011760:Pyrrolidinones; D000077287:Levetiracetam; C482793:brivaracetam; D010889:Piracetam